Search details
1.
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4ß7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(5): 697-705.e7, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29223444
2.
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
J Crohns Colitis
; 18(3): 341-348, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-37691574
3.
The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful.
Gut
; 60(1): 41-8, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20519742
4.
Inflammatory bowel disease: an emergent disease among Ethiopian Jews migrating to Israel.
Inflamm Bowel Dis
; 21(3): 631-5, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25581835
5.
Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies.
Inflamm Bowel Dis
; 18(9): 1628-33, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22038899
Results
1 -
5
de 5
1
Next >
>>